Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05269745
Other study ID # 25940
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 17, 2022
Est. completion date September 30, 2024

Study information

Verified date March 2024
Source Medical University of Graz
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Neurologic changes caused by cerebral palsy (CP) result in adaptation of muscle architecture and function (e.g. shortened muscles and contractures). Stretching through immobilization (orthotic treatment) is one of the common interventions to bring the spastic muscle to growth. Positive outcomes of stretching through immobilization are increased range of motion and improved function. On the other hand, immobilization leads to disuse muscle atrophy. Hence, we hypothesize that combining a stretching through immobilization and muscle activity while controlling for foot deformity could be a superior treatment approach, which should lead to improved muscle morphology as well as function. The aim of the study is to examine the influence of two orthotic treatments (a standard regime and one new approach) on spastic plantar flexor muscles in children and adolescents with CP. The standard regime (stretching through immobilisation) includes a dynamic AFO (ankle-foot orthosis) used during day and night. The new approach combines stretching through immobilisation and allows for plantarflexor activity due to an innovative construction of the orthotic device. This prospective randomized controlled study will recruit 20 ambulant children and adolescents (aged 5 to 15 years) with cerebral palsy and equinus deformity (GMFCS = Gross Motor Function Classification System level I to III). Each child will be randomized and stratified according to age and GMFCS to one of two groups. The first group receives the standard treatment (stretching through immobilization) using custom-made ankle foot orthosis for 23 hours per day. The other group will be treated with the same orthosis at night (8 hours) and for 6 hours during the day but the remaining 10 hours will be treated with the foot shell only that corrects subtalar and Chopart joints but does not block the ankle joint movement, so that more activity of plantarflexors will be possible during the day. The intervention will last for 12 weeks. Each child will be examined at four occasions (8 weeks before intervention = control phase, at the beginning of the intervention and then 8 and 12 weeks later). The main outcome measure is the fascicle length measured using a 3D ultrasound (3DUS) imaging technique. Further parameters of interest span across the whole levels of ICF including clinical examinations, biomechanics of gait, muscle morphologic and mechanic properties and participations questionnaires.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 20
Est. completion date September 30, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers No
Gender All
Age group 5 Years to 15 Years
Eligibility Inclusion Criteria: - Ambulatory children with spastic CP. - Ability to accept and follow verbal instruction. - Limited range of motion in ankle joint - maximal dorsiflexion with knee extended = 5° - Gross Motor Functional Classification System level I-III. - Age 5-15 years. - Willingness to participate. Exclusion Criteria: - Other than spastic form of CP (ataxic, athetoid or dystonic). - Severe mental retardation. - Normal range of motion in ankle joint - Oral antispastic or muscle relaxing medication. - History of orthopaedic surgery in the last 12 months. - History of botulinum toxin type A application in the last six months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Stretching through immobilisation (IG)
The immobilization group (IG) will receive the standard treatment, a dynamic ankle-foot orthosis (AFO) for night and day use (23 hours per day)
Stretching through immobilisation and activity (IAG)
The Immobilization/Activity Group (IAG) will be treated with the same type of ankle-foot orthosis at night (8 hours) and for 6 hours during the day (altogether orthosis treatment 14 hours per day). The rest of the day (10 hours) children and adolescents will be using only the foot shell of orthoses (FS) without the lower leg shell, to secure the correct position of the foot and to allow a free motion at ankle joint with a good correction of the foot deformity (e.g. Pes equinovarus / equinovalgus, midfoot-break).
Control Phase
Before the intervention with the orthotic treatment starts, a control phase of 8 weeks is planned. During this time, the individual orthoses for each subject are manufactured.

Locations

Country Name City State
Austria Medical University Graz Graz Styria

Sponsors (2)

Lead Sponsor Collaborator
Medical University of Graz University of Graz

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in mechano-morphological muscle-tendon properties - muscle volume Gastrocnemius medialis muscle volume Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
Primary Change in mechano-morphological muscle-tendon properties - fascile length Gastrocnemius medialis fascile length Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
Primary Change in mechano-morphological muscle-tendon properties - unit length Gastrocnemius medialis muscle belly, tendon and muscle-tendon unit length Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
Primary Change in mechano-morphological muscle-tendon properties - elongation Passive gastrocnemius medialis muscle belly, tendon and muscle-tendon unit elongation due to externally applied torque to the ankle joint [elongation in mm] Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
Primary Change in mechano-morphological muscle-tendon properties - stiffness Passive gastrocnemius medialis muscle belly, tendon and muscle-tendon unit stiffness due to externally applied torque to the ankle joint [stiffness in N/mm] Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
Primary Change in joint range of motion Ankle joint range of motion (maximal plantarflexion - maximal dorsiflexion) Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
Primary Change in maximal isometric muscle strength Maximal isometric torque production (isokinetic dynamometry) Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
Primary Change in gait characteristics Gait kinematics (joint angles [°]) and kinetics (joint moments [Nm/kg]) of the hip, knee, and ankle joints (3D motion capture). Joint angles [°] and moments [Nm/kg] will be combined to report changes in gait pattern. Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
Secondary Change in self-reported gait, mobility, and functional performance - GOAL Gait Outcomes Assessment List (GOAL) Questionnaire Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
Secondary Change in self-reported gait, mobility, and functional performance - PODCI Pediatrics Outcomes Data Collection Instrument (PODCI) Questionnaire Time Frame: baseline (T1), PRE-measurement (T2, 8 weeks), POST-measurement (T3, 16 weeks), FOLLOW-UP measurement (T4, 20 weeks)
See also
  Status Clinical Trial Phase
Recruiting NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) N/A
Not yet recruiting NCT05131724 - Effectiveness of Virtual Reality on Functional Mobility During Treadmill Training in Children With Cerebral Palsy N/A
Completed NCT03005938 - Influence of the Spinal Manipulation on Muscle Spasticity and Manual Dexterity in Cerebral Palsy. N/A
Completed NCT04087330 - Whole-body Vibration in Spastic Hemiplegic Cerebral Palsy N/A
Completed NCT04570358 - Stretching in Children and Adolescents With Spastic Cerebral Palsy N/A
Completed NCT05945953 - Incentive Spirometer as a Visual Feedback in Children With Spastic Cerebral Palsy N/A
Completed NCT03209310 - The Effect of Trunk Control on Respiratory Muscle Strength N/A
Recruiting NCT03361930 - Changes in Muscle Activity of Children With Spastic Unilat Cerebral Palsy Using 2 Types of Ankle-foot Orthoses to Walk N/A
Recruiting NCT05593887 - Late-presenting Hip Dislocation in Non-ambulatory Children With Cerebral Palsy: A Comparison of Three Procedures N/A
Recruiting NCT03677843 - Multidimensional Approach in Patients With Severe Cerebral Palsy, Prospective Cohort(MAPCP Cohort)-Offline
Recruiting NCT03179241 - Outcome After Selective Dorsal Rhizothomy Concerning Life Quality, Cerebral Imaging and Cognition
Not yet recruiting NCT06434246 - Effect of Pully System on Hemiplegic Children N/A
Recruiting NCT05627921 - The Effect of Botulinum Toxin and ESWT Applications on Spasticity and Functionality in Cerebral Palsy Patients N/A
Completed NCT05102955 - Turkish Validity and Reliability of the Visual Function Classification System (VFCS)
Recruiting NCT06330922 - Muscle-tendon Pathology and Metabolic Dysregulation in CP
Completed NCT05251519 - The Efficacy of Derotation Banding on Outcome Measures in Children With Cerebral Palsy N/A
Completed NCT05251532 - The Efficacy of Distortion Banding on Outcome Measures in Children With Cerebral Palsy N/A
Completed NCT05115695 - The Effect of Upper Extremity Strengthening on Functionality, Muscle Strength and Trunk in Children With Cerebral Palsy N/A
Completed NCT04240275 - Reliability of a Body-worn Sensor System for Gait Analysis in Children With CP
Not yet recruiting NCT05198921 - The Effectiveness of Repetitive Transcranial Magnetic Stimulation for Spastic Diplegia Cerebral Palsy N/A